ArticleWellcome open research2021

AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trial.

Ying Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.